Lipo-C is an injectable blend offered by compounding pharmacies and medical spas, closely related to Lipo-B but marketed as an enhanced or “more comprehensive” variant. Vendor and clinic sources genuinely disagree on what actually distinguishes Lipo-C from Lipo-B: some describe it as the same lipotropic base (methionine, inositol, choline) with vitamin C substituted for the B-vitamin component, while others describe it as the same base plus added L-carnitine and additional B-complex vitamins. This page documents both descriptions rather than picking one silently.
Research snapshot
| Peptide category | Compounded lipotropic/vitamin injection blend (not a peptide product) |
| Primary research interest | Marketed as an enhanced variant of Lipo-B for weight-management support alongside diet and exercise |
| Highest available evidence | Tier 6 — no clinical trial of this specific combined formulation was identified; component ingredients have their own separate nutritional evidence |
| Human research available | No trial of the combined shot as sold; individual components (methionine, inositol, choline, vitamin C or L-carnitine/B-complex) have general nutritional/metabolic literature |
| Development status | Not a formulated drug product; a compounding-pharmacy preparation that varies by clinic |
| Regulatory status | Not an FDA-approved drug product; prepared under state pharmacy compounding rules |
| Last reviewed | September 2026 |
Technical identity (composition)
| Primary name | Lipo-C (vendor/clinic name) |
| Composition | Shares the same “MIC” lipotropic base as Lipo-B (methionine, inositol, choline). Sources genuinely disagree on what is added: some describe the B-complex vitamins replaced with vitamin C (ascorbic acid); others describe the same base plus added L-carnitine and additional B-complex vitamins |
| Share of vial by mass | Not standardised — exact ratios, concentrations, and even which ingredients are included differ between compounding pharmacies and clinics, and between the two competing descriptions of the product itself |
| Peptide sequence | Not applicable — this is a vitamin/amino-acid blend, not a peptide |
| Molecular formula | Not applicable — a multi-component mixture, not a single molecular entity |
| CAS Registry Number | Not applicable — no CAS number is assigned to the combination itself |
| Chemical modifications | Not applicable — unmodified nutrients/vitamins |
| Developer or originator | Not applicable — a compounding-pharmacy/clinic preparation, not a developed drug product |
| Development status | Not in formal development; no INN, no approved status |
What is typically in it
Across the sources reviewed, Lipo-C consistently shares the same “MIC” lipotropic base as Lipo-B — methionine, inositol, and choline. Where sources diverge is what is added or substituted on top of that base: one common description states that Lipo-C replaces some or all of the B-complex vitamins used in Lipo-B with ascorbic acid (vitamin C), marketed for antioxidant support during rapid weight loss. A different, also commonly repeated description states that Lipo-C adds L-carnitine (to support fatty-acid transport into cells) plus additional B-complex vitamins on top of the MIC base, rather than substituting vitamin C for the B vitamins. PeptideBlog.net was not able to identify an authoritative, independent source that resolves which of these descriptions is more accurate, or whether both exist as genuinely different products sold under the same commercial name by different compounders.
As with Lipo-B, Lipo-C is typically prepared by compounding pharmacies rather than sold as a single standardized manufactured product, so exact composition, concentration, and which of the above formulas is used will vary by clinic.
Why the name became popular / clinical use
Lipo-C appears to have emerged as a marketing variant of the older Lipo-B lipotropic-injection concept, positioned by many clinics as a “step up” or more comprehensive option, whether through added vitamin C or added L-carnitine, depending on the compounder. As with Lipo-B, the name functions as a clinic marketing label rather than a name tied to a specific clinical trial or regulatory approval.
Has the combination itself been studied?
The individual components potentially included in Lipo-C — methionine, choline, inositol, vitamin C, L-carnitine, and B-complex vitamins — each have some independent research behind their individual biological roles (vitamin C in antioxidant and collagen-related processes; L-carnitine in fatty-acid transport, discussed in more detail in this site’s separate L-Carnitine entry). No published, controlled clinical trial evaluating the specific combined Lipo-C injectable formulation itself was identified, regardless of which of the two commonly described formulas is used. As with Lipo-B, individually studied ingredients do not establish that this specific combination has been clinically validated for weight loss.
What dosage information circulates?
Figures in this section summarize amounts and schedules reported by compounding pharmacies, med spas, and clinic marketing. Their inclusion documents what is reported and does not establish that a regimen is verified, safe, effective, or appropriate.
Reported clinic and compounding-pharmacy formulations
Sources describing the vitamin-C variant commonly list the same MIC base as Lipo-B (approximately 25 mg methionine, 50 mg inositol, 50 mg choline) with roughly 100-250 mg ascorbic acid added or substituted in place of some B vitamins. Sources describing the L-carnitine variant commonly list the same MIC base plus an added L-carnitine component (specific circulating amounts were not consistently reported) and additional B-complex vitamins. This is vendor/practitioner-reported information (Tier 5/6) and not a standardized clinical dose; exact amounts and even which ingredients are used vary by compounder.
Reported use patterns
Weight-loss clinics and med spas commonly describe weekly intramuscular injections, generally as an adjunct to a supervised diet and exercise program, similar to how Lipo-B is used. This use pattern is practitioner/vendor-reported and not derived from a controlled trial of the Lipo-C formulation itself.
Combinations and related research
Formally studied: none identified for the Lipo-C combination as a whole, under either commonly described formula. Mechanistically plausible: individual components (methionine, choline, inositol, and either vitamin C or L-carnitine plus B-complex vitamins, depending on the version) each have some biological rationale from separate research on each ingredient. Practitioner-reported: clinics commonly market Lipo-C alongside diet programs or prescription weight-loss medications as a package, similar to Lipo-B. Community-reported: online discussion typically treats Lipo-B and Lipo-C as roughly interchangeable “lipo shot” options without distinguishing which formula a given clinic is actually providing.
What circulates E5
| Reported use | Route | Amount reported | Frequency | Reported length |
|---|---|---|---|---|
| Weight-loss support adjunct (clinic/med-spa use) | Intramuscular injection | MIC base + vitamin C or L-carnitine (varies) | Weekly | Several weeks to months, per clinic protocol |
Clinic and compounding-pharmacy sources commonly describe a weekly intramuscular injection built on the same MIC base as Lipo-B, with either roughly 100-250 mg added vitamin C, or added L-carnitine plus additional B-complex vitamins, depending on the source.
This is vendor/practitioner-reported information; exact composition is not standardized, the two commonly circulated descriptions of Lipo-C genuinely conflict, and no controlled trial of either version of the combined product was identified.
Recorded as an observation about what is published elsewhere. No figure here is a dose, a protocol, or a recommendation, and nothing in this section is evidence that any amount is safe or effective.
Side effects, risks, and limitations
Reported side effects are similar to those described for Lipo-B: injection-site soreness and occasional gastrointestinal upset. As a compounded product, formulation consistency, sterility, and accurate ingredient labeling depend on the individual compounding pharmacy. The unresolved disagreement over what Lipo-C actually contains is itself a practical concern — a patient switching clinics may receive a meaningfully different product under the same name. No systematic, formulation-specific safety trial for Lipo-C was identified.
Regulatory and developmental status
Lipo-C is not an FDA-approved drug product; like Lipo-B, it is typically prepared by compounding pharmacies under state pharmacy regulation rather than as a single, federally approved formulation. No FDA approval exists for this combination for weight loss or any other indication. Status verified as of the review date below.
Frequently asked questions
What is Lipo-C?
Lipo-C is a compounded injectable blend built on the same methionine-inositol-choline (MIC) base as Lipo-B, marketed as an enhanced variant, though sources disagree on whether the enhancement is added vitamin C or added L-carnitine plus B-complex vitamins.
How is Lipo-C different from Lipo-B?
Both share the same MIC lipotropic base. Some sources describe Lipo-C as substituting vitamin C for some B vitamins used in Lipo-B; other sources describe it as adding L-carnitine and more B-complex vitamins on top of the same base. PeptideBlog.net could not resolve which description is more accurate and documents this as an open conflict.
Does Lipo-C cause weight loss on its own?
No controlled clinical trial of the combined formulation, under either commonly described version, was identified. It is typically marketed as an adjunct to diet and exercise, not as a standalone treatment.
What dosage commonly circulates for Lipo-C?
Depending on which formula a source describes, reported amounts include roughly the same MIC base as Lipo-B plus either 100-250 mg vitamin C, or added L-carnitine and B-complex vitamins, generally given weekly. This is vendor-reported and not standardized.
Is Lipo-C FDA approved?
No. It is a compounded product, not an FDA-approved drug formulation.
Bottom line
Lipo-C is a compounded lipotropic injectable built on the same base as Lipo-B, marketed as a more comprehensive variant, but the market itself is inconsistent about what specifically makes it different — added vitamin C versus added L-carnitine and B-complex vitamins are both commonly claimed. As with Lipo-B, no clinical trial of the combined product was identified, and readers should not assume that individually well-studied ingredients make this specific blend a validated weight-loss treatment.